The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: Definitions, incidence, risk factors and outcome

Leprosy Review

Volumn 71, Issue 3, 2000, Pages 285-308

  Saunderson, Paul ^a   Gebre, Shibru ^a   Desta, Ketsela ^a   Byass, Peter ^b,c   Lockwood, Diana N J ^d  

^a All Africa Leprosy Tuberculosis and Rehabilitation Training Centre Addis Ababa   (Ethiopia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; ETHIOPIA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEPROSY; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; NERVE FUNCTION; NERVE LESION; NEUROPATHY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; SENSORY NERVE;

EID: 0033729620     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.20000033     Document Type: Article

References (37)

1. The management of leprosy reversal reactions (Editorial)
2. The management of erythema nodosum leprosum: Current and future options
3. Silent neuropathy in leprosy: An epidemiological description
4. Kellersberger Memorial Lecture 1998: Nerve damage in leprosy: A problem for patients, doctors and scientists
5. Reversal reactions in leprosy and their management
6. Nerve function impairment in leprosy at diagnosis and at completion of MDT: A retrospective cohort study of 786 patients in Bangladesh
7. Nerve damage in leprosy: An epidemiological and clinical study of 396 patients in west Nepal - Part 1 Definitions, methods and frequencies
8. The occurrence of reactions and impairments in leprosy: Experience in the leprosy control program of three provinces in northeastern Thailand, 1978-1995 III Neural and other impairments
9. Incidence rates of acute nerve function impairment in leprosy: A prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study)
10. Peripheral autonomic nerve dysfunction in asymptomatic leprosy contacts
11. Inter-observer variability in the assessment of nerve function in leprosy patients in Ethiopia
12. Reference values for touch sensibility thresholds in healthy Nepalese volunteers
13. Intertester reliability of manual muscle strength testing in leprosy patients
14. Functional sensibility of the hand in leprosy patients
15. Sensory testing of the hand in leprosy
16. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions
17. Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi
18. The significance of facial patches and type I reaction for the development of facial nerve damage in leprosy A retrospective study among 1226 paucibacillary leprosy patients
19. Risk factors for type 1 reactions in leprosy
20. Risk factors for type-1 reactions in borderline leprosy patients
21. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia
22. Reactions in leprosy: An epidemiological study of 386 patients in west Nepal
23. Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?
24. Pregnancy and leprosy: A comprehensive literature review
25. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients
26. The management of nerve damage in the leprosy control services
27. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: The AMFES project, part 2. Reactions and neuritis during and after MDT in PB and MB leprosy patients
28. Field evaluation of WHO-MDT of fixed duration at ALERT, Ethiopia: The AMFES project-I MDT course completion, case-holding and another score for disability grading
29. Grading impairment in leprosy
30. Delay in presentation and start of treatment in leprosy patients: A case-control study of disabled and non-disabled patients in three different settings in Ethiopia
31. Factors associated with impairments in new leprosy patients: The AMFES cohort
32. Field comparison of 10-g and 1-g filaments for the sensory testing of hands in Ethiopian leprosy patients
33. Nerve function impairment in leprosy: Design, methodology and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study)
34. The occurrence of reactions and impairments in leprosy: Experience in the Leprosy Control Program of three Provinces in Northeastern Thailand, 1978-1995. 1. Overview of the study
35. Field treatment of acute nerve function impairment in leprosy using a standardized corticosteroid regimen - First year's experience with 100 patients
36. Nerve function impairment in leprosy: An epidemiological and clinical study - Part 2: Results of steroid treatment
37. The treatment of acute nerve function impairment in leprosy: Results from a prospective cohort study in Bangladesh